NO20053726D0 - Forbindelser med prolyloligopeptidase-hemmende aktivitet - Google Patents

Forbindelser med prolyloligopeptidase-hemmende aktivitet

Info

Publication number
NO20053726D0
NO20053726D0 NO20053726A NO20053726A NO20053726D0 NO 20053726 D0 NO20053726 D0 NO 20053726D0 NO 20053726 A NO20053726 A NO 20053726A NO 20053726 A NO20053726 A NO 20053726A NO 20053726 D0 NO20053726 D0 NO 20053726D0
Authority
NO
Norway
Prior art keywords
compounds
inhibitory activity
prolyl oligopeptidase
oligopeptidase inhibitory
prolyl
Prior art date
Application number
NO20053726A
Other languages
English (en)
Other versions
NO20053726L (no
Inventor
Tomi Jarvinen
Jouko Vepsalainen
Johannes A M Christiaans
Elina Jahro
Pekka Mannisto
Taija Saarinen
Jukka Ghynter
Erik Wallen
Markus Forsberg
Antti Poso
Jarkko Venalainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20053726D0 publication Critical patent/NO20053726D0/no
Publication of NO20053726L publication Critical patent/NO20053726L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
NO20053726A 2003-01-03 2005-08-03 Forbindelser med prolyloligopeptidase-hemmende aktivitet NO20053726L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030014A FI20030014A0 (fi) 2003-01-03 2003-01-03 Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä
PCT/FI2004/000001 WO2004060862A2 (en) 2003-01-03 2004-01-02 Compounds having prolyl oligopeptidase inhibitory activity

Publications (2)

Publication Number Publication Date
NO20053726D0 true NO20053726D0 (no) 2005-08-03
NO20053726L NO20053726L (no) 2005-09-28

Family

ID=8565256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053726A NO20053726L (no) 2003-01-03 2005-08-03 Forbindelser med prolyloligopeptidase-hemmende aktivitet

Country Status (18)

Country Link
US (1) US20060229254A1 (no)
EP (1) EP1581489A2 (no)
JP (1) JP2006516557A (no)
KR (1) KR20060027789A (no)
CN (1) CN1747930A (no)
AU (1) AU2004203788A1 (no)
BR (1) BRPI0406618A (no)
CA (1) CA2511856A1 (no)
EA (1) EA010022B1 (no)
FI (1) FI20030014A0 (no)
HR (1) HRP20050693A2 (no)
IS (1) IS7963A (no)
MX (1) MXPA05007262A (no)
NO (1) NO20053726L (no)
PL (1) PL378329A1 (no)
RS (1) RS20050514A (no)
WO (1) WO2004060862A2 (no)
ZA (1) ZA200505183B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2513053T3 (pl) 2009-12-18 2018-03-30 Ogeda Sa Pochodne kwasu pirolidyno-karboksylowego jako agoniści receptora 43 sprzężonego z białkiem G (GPR43), kompozycja farmaceutyczna i sposoby do zastosowania w leczeniu zaburzeń metabolicznych
EP2730571A1 (en) 2012-11-12 2014-05-14 Universitat De Barcelona 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
EP3610872A1 (en) * 2013-11-27 2020-02-19 Epics Therapeutics Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
KR101913506B1 (ko) * 2017-07-18 2018-10-30 경상대학교산학협력단 프롤릴 올리고펩티다아제 억제제를 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 조성물
CN117545738A (zh) 2020-07-07 2024-02-09 安克瑞治疗公司 1-[1-(4-苄氧基-3,5-二氟-苯甲酰基)-4-氟-吡咯烷-2-羰基]吡咯烷-2-腈

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483991A (en) * 1983-01-17 1984-11-20 American Home Products Corporation Hypotensive agents
CA1309805C (en) * 1985-04-16 1992-11-03 Naoki Higuchi Dipeptide derivative and synthesis and use thereof
JPH0696563B2 (ja) * 1986-02-04 1994-11-30 サントリー株式会社 アシルアミノ酸誘導体、その製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
CA2084412C (en) * 1990-06-04 2000-05-09 W. Stephen Faraci Pyrrolidine and thiazolidine amides
AU643300B2 (en) * 1990-06-07 1993-11-11 Zeria Pharmaceutical Co., Ltd. Novel arylalkanoylamine derivative and drug containing the same
ES2182203T3 (es) * 1997-10-31 2003-03-01 Hoffmann La Roche Derivados de d-prolina.

Also Published As

Publication number Publication date
FI20030014A0 (fi) 2003-01-03
IS7963A (is) 2005-07-28
JP2006516557A (ja) 2006-07-06
ZA200505183B (en) 2006-04-26
BRPI0406618A (pt) 2005-12-06
US20060229254A1 (en) 2006-10-12
NO20053726L (no) 2005-09-28
EP1581489A2 (en) 2005-10-05
CN1747930A (zh) 2006-03-15
WO2004060862A2 (en) 2004-07-22
CA2511856A1 (en) 2004-07-22
WO2004060862A3 (en) 2004-11-25
EA200501083A1 (ru) 2006-02-24
MXPA05007262A (es) 2005-09-08
EA010022B1 (ru) 2008-06-30
PL378329A1 (pl) 2006-03-20
RS20050514A (en) 2007-12-31
AU2004203788A1 (en) 2004-07-22
KR20060027789A (ko) 2006-03-28
HRP20050693A2 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
IS8322A (is) Tálmar Akt virkni
DK1775298T3 (da) Thienopyrazolderivat med PDE7-inhibitorisk aktivitet
DK1594840T3 (da) Piperidin-benzensulfonamid-derivater
IS8320A (is) N-staðgengnir pýrasólýl-amidýl-bensimidasólýl
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
SE0302991L (sv) Spånskiva
NO20054405D0 (no) Kjemokinreseptor-binende heterosykel
ATE420066T1 (de) Amidoacetonitrilderivate
ATE352550T1 (de) Chinazolinderivate
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DE602004019555D1 (de) Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone
DK1510667T3 (da) Lyddæmper
IS8045A (is) Púrín-6-ón-afleiður
DK1682129T3 (da) N-thiazol-2-ylbenzamidderivater
NO20053726D0 (no) Forbindelser med prolyloligopeptidase-hemmende aktivitet
ATA17802003A (de) Möbelanordnung
DK1706373T3 (da) Amidoacetonitrilderivater
ITMI20030397V0 (it) Cassetto
DK1594859T3 (da) Indazolamider med analgetisk aktivitet
ATE514681T1 (de) N-substituierte pyrazolylcarboxanilide
DE602004013284D1 (de) Schalldämpfer
DE60328233D1 (de) Sulfamatbenzothiophenderivate als steroidsulfataseinhibitoren
ATE357603T1 (de) Befestigungsanordnung
NO20030513D0 (no) Möbel
FI20021817A (fi) Kanyyli

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application